Our Pipeline

Our unique IND engine has helped us identify novel pathways and targets in immuno-oncology and other areas.

Oncology-Focused Pipeline with Multiple Clinical Candidates

CSF-1R antibody

2L pancreatic cancer (Combination with Opdivo® and chemo)

1L maintenance Stand Up To Cancer and BMS supported trial (with Opdivo®)

Multiple tumor settings (Combination with Opdivo®)

Apexigen & BMS supported trial for APX005M (anti-CD40), cabira and Opdivo®

FGFR2b antibody

FIGHT Phase 3 trial (with chemo) in gastric/GEJ cancer

B7-H4 antibody

Multiple tumor settings

CD80-Fc

Multiple tumor settings

TIM-3 antibody

Phase 1/2 trial in multiple tumor settings

Multiple tumor settings

Multiple tumor settings